This study presents regression and classification models to predict human intestinal absorption of 645 drug and drug like compounds using percentage human intestinal values from the published dataset by Hou et al (2007c) . The problem with this dataset and other datasets in the literature is there are more highly than poorly absorbed compounds. Any models developed using these datasets will be biased towards highly absorbed compounds and not applicable for use in industry where now more compounds are likely to be poorly absorbed. The study compared two training sets, TS1, a balanced (50:50) distribution of highly and poorly absorbed compounds created by under-sampling the majority high absorption compounds, with TS2, a randomly selected training set with biased distribution towards highly absorbed compounds. The regression results indicate that the best models were those developed using the balanced dataset (TS1). Also for classification, TS1 led to the most accurate models and the highest specificity value of 0.949. In comparison, TS2 led to the highest sensitivity with a value of 0.939. Thus, under-sampling the majority class of the highly absorbed compounds leads to a balanced training set (TS1) that can achieve more applicable in silico regression and classification models for the use in the industry.
Introduction
Drug discovery has changed from primarily focusing on efficacy and selectivity of new drug candidates to incorporating the testing of absorption, distribution, metabolism, elimination and toxicity (ADMET) properties with high throughput (HT) in vitro and in vivo assays (Davis et al. 2005; Gleeson et al. 2011) . With the help of these assays plus the development of HT automation, drug candidates failing due to undesirable ADMET properties in Phase 1 clinical trials have been reduced from ~40% in 1991 to ~10% in 2000 (Kennedy 1997; Kola and Landis 2004) .
In silico modelling of ADMET properties particularly absorption has become a focus for pharmaceutical companies due to the need to eliminate unsuitable compounds before too much resource has been spent (Boobis et al. 2002; Smith 2002; Tsaioun et al. 2009 ). Reliable and robust in silico models would mean a cost effective way of predicting desirable/undesirable properties or act as a tool to help select the appropriate assays to perform based on chemical structure and physiochemical properties (Geerts and Heyden 2011; van de Waterbeemd and Gifford 2003) .
Oral absorption in particular is a primary focus for in silico modelling because it is the easiest and most convenient route for administration that achieves patient acceptance, rather than other routes that cause discomfort or inconvenience (Ashford 2007; Hou et al. 2009 ). In silico modelling can be used to predict intestinal absorption (percentage human intestinal absorption -%HIA or fraction absorbed -FA) and/or oral bioavailability (F). Confusion can sometimes be caused by these terms and acronyms as they are sometimes used interchangeably and are often coupled together (Burton et al. 2002; Zhao et al. 2001) .
Intestinal absorption has been defined as the amount of drug that passes through the intestinal tissue and enters the portal vein (Hou et al. 2009; Sinko 1999 ). This contrasts with bioavailability, which is described as the fraction of drug dose that reaches the systemic circulation unchanged after first pass metabolism (Kwon 2002; Zhu et al. 2011) . Hou et al (2009) found that the bioavailability of 64% of compounds they analysed were governed by absorption, therefore accurate predictions of intestinal absorption are required as this is the prerequisite to predicting oral bioavailability with accuracy and precision. Bioavailability is complex and dependant on many other variables, therefore making it a challenge to predict with any model (Zhu et al. 2011) .
For a drug to be orally absorbed it needs to cross the intestinal membrane. The predominant route for most drugs is passive diffusion, mainly transcellular. However, some small polar compounds can exit through the interstitial space between cells; this is known as paracellular diffusion. Both are driven by concentration gradients (Kay 2011) . Recently, the mechanisms of drug transport through biological membranes have been re-evaluated as a result of discoveries made in the area of human genome mapping and identification of a vast number of proteins involved in transporting drugs across membranes (Al-Awqati 1999) . These transporters can either increase the movement of the drug into the cell, known as active transport, or enhance movement of drugs out of cell, known as efflux. Each will affect absorption of the drug by increasing or decreasing it respectively (Giacomini et al. 2010; Kerns and Di 2008) .
There are various published papers using simple predictions based on Quantitative StructureActivity Relationships/Quantitative Structure-Property Relationships (QSAR/QSPR) for predicting intestinal absorption. Lipinski"s "Rule of five" is the most commonly known method used in drug discovery settings (Lipinski et al. 1997 ). Lipinski states that if two of the rules are breached then poor absorption is highly likely; these are if molecular weight >500 Da, sum of OH and NH hydrogen bond donors >5, calculated logP (C LogP) >5 and sum of N and O atoms as hydrogen bond acceptors >10. Although these rules are for qualitative purposes and have been criticised, the descriptors can be used to generate quantitative predictions (Hou et al. 2007b; Lagorce et al. 2011; Macheras and Iliadis 2006) . Zhao et al (2002) and Veber et al (2002) both have used simple predictive models. The basis of these simple models are physiochemical properties of the compounds that are physiologically related to intestinal absorption, for example polar surface area (PSA) and logD have been referenced to be important descriptors (van de Waterbeemd and Gifford 2003) . PSA is the area of the Van der Waals surface that arises from oxygen and nitrogen atoms or hydrogen atoms bound to these atoms, and is also related to size and has a negative correlation with intestinal absorption. LogD is the logarithm of apparent distribution coefficient between octanol and water, and a measure of hydrophobicity at a specific pH. In order to be absorbed the compound must be hydrophobic enough to permeate the cell membrane. There are also more sophisticated models to improve these predictions. Models produced by data analysis methods such as Genetic Algorithms (GA), Artificial Neural Networks (ANN) and Support Vector Machines (SVM) are being developed due to increase in demand for improved accuracy of predictions (Hou et al. 2007a; Tian et al. 2011 ). The problem with the currently available models is that they are based on training sets with unbalanced data distribution due to the greater number of highly absorbed compounds present in the datasets. This creates biased models which have better ability at predicting highly absorbed compounds than poorly absorbed compounds (Wessel et al. 1998; Zhao et al. 2002) .
In order for a better more applicable well balanced dataset to be achieved, more compounds in the low/medium absorption range will need to be added (Gleeson et al. 2011; Oprea et al. 2007; Yan et al. 2008) .
In this paper, in silico models that focus on predicting passive intestinal absorption using classification and regression methods for relating the absorption to the physiochemical and structural properties of drugs are developed and evaluated. The dataset used is taken from Hou et al (2007c) . This paper addresses the problem of unbalanced data distribution by creating a balanced training set through under-sampling the highly absorbed compounds. In doing so, this paper seeks to achieve a more applicable model with a better prediction capacity of poorly absorbed compounds without jeopardizing the prediction accuracy for the highly absorbed drugs.
Methods & Materials

Datasets of Intestinal Absorption in Humans
The dataset used consisted of Human Intestinal Absorption (%HIA) data for 647 drugs and drug-like compounds extracted from SDF format from the supporting information of the paper, which is freely available on the internet (http://cadd.suda.edu.cn/admet/) and is the largest compilation of data for those drugs to date (Hou et al. 2009 ). This dataset contains intestinal absorption (%HIA) of 647 passively absorbed drugs with a wide variety of pharmacological and chemical classes. It was found that 2 compounds (Sulfamethazine & Glycine) were duplicated in the initial set so the duplicates were removed, giving a first initial total of 645 compounds. From the 645 drugs, in the dataset Hou et al (2007c) excluded 95 compounds. 43 were absorbed via carrier mediated transporters, 24 had poor solubility problems, 26 contained ammonium groups, and for 2, logD could not be calculated. The significance of the quaternary ammonium group is that complications may arise due to different levels of ion pairing which may be affected by the formulation and stomach content, although there has been ambiguity regarding the effectiveness of ion-pair related absorption levels . In this study, the 26 compounds containing ammonium groups were excluded entirely to avoid the added complications. The remaining 619 compounds were used in the analyses. "Upon exclusion of the 95 compounds" means the exclusion of the remaining 69 compounds, as the 26 compounds containing quaternary compounds have already been removed.
The dataset was split into two groups, a training set and a validation set. The training set is used to build the classification and regression models and the validation set is used to measure the accuracy of the models and then select the best model. From the same original dataset, different training sets were created that had different numbers of compounds and the remaining compounds or a selection of the remaining compounds were used as the validation sets. Table 1 is a summary of the compound numbers assigned to the training and validation sets for the different splits of the datasets. The next section describes the rationale behind partitioning the dataset into training and validation sets. 
TS1-VS1
As the dataset contains a majority of highly absorbed compounds, a randomly selected training set could be biased towards this type of drugs. To overcome this problem, a balanced training set was devised. The compounds were sorted according to %HIA and then logP values. 10 categories of %HIA, which contained about 10 drugs in each 10% range of %HIA was attempted and selected randomly for the training set. In the original dataset there are more examples of the highly absorbed compounds in the ranges of 80-100% HIA than poorly absorbed compounds in the lower ranges. By taking 10 samples from each %HIA range under-sampling the majority class is achieved due to the larger number of highly absorbed compounds being removed and not used compared with the poorly absorbed class. The remaining compounds were used as the validation set (VS1). Under-sampling the majority class (high absorption compounds) gave a more balanced training set with similar numbers of low and high absorption drugs in the training set.
TS2-VS2
The dataset was initially sorted based on ascending %HIA and then logP values. Then from each group of six consecutive compounds, five were assigned to the training set, and one compound was allocated to the validation set randomly. This ensured similar distribution of %HIA values in the training and validation sets. The training set contained 496 and the validation set contained 100 compounds. This dataset is unbalanced and not under-sampled and is more like the %HIA distribution of the original dataset with a higher proportion of highly absorbed compounds in the training and validation sets.
Exclusion of outliers
The removal of the 95 compounds as highlighted by Hou et al (2007c) from the dataset reduced the number of compounds in the training and validation sets. The final numbers left in the training and validation sets after these 95 compounds were removed was for TS1, 73
and 477 and for TS2, 458 and 92 respectively. Removing the outliers did not affect the balance of high to low absorption compounds significantly for VS1, VS2, VS3 or TS2. For TS1 the balance changed towards highly absorbed compounds from the initial 50:50 split to 33:67.
VS3 -New balanced validation set with 89 compounds
Comparing the models that are developed using TS1 and TS2 training sets would not be a fair comparison if validation sets are not similar. In particular for the dataset TS1 the initial validation set, VS1, (of 502 compounds) consisted of all the remaining compounds not used in the training set, therefore a drawback is recognised that the training and validation sets have different %HIA distributions. In other words, not only the validation sets of TS1 and TS2 are very different in terms of the number of the compounds, for TS1, the validation set is not a correct representation of the training set as the %HIA distributions are very different.
As such, a new validation set, VS3, containing 89 compounds was selected as follows. After selection of TS1, from the remaining 502 compounds (VS1), 89 compounds were selected randomly by under-sampling the highly absorbed compounds (VS3). It was ensured that none of the TS2 compounds were included in this validation set. This new validation set had a similar %HIA distribution to the TS1 training set, i.e. roughly similar number of compounds within each 10% band of %HIA, therefore making direct comparisons between all the models comprehensible when using the results from the validation set VS3.
Molecular Descriptors
A total of 215 descriptors were used in this study. A variety of different software packages were used to compute these descriptors, they include TSAR 3D (Accelrys Inc), MDL QSAR (Symyx Inc.), Kowwin (U.S. EPA) and Advanced Chemistry Development ACD Labs/ LogD
Suit. Due to software restraints some molecular descriptors could not be calculated for some compounds in the dataset.
Selection of Molecular Descriptors for Models
Several regression and classification models were developed using molecular descriptors of the compounds. The descriptors used in these models were:
1. Descriptors selected by stepwise regression analysis.
2. Descriptors selected by stepwise discriminant analysis.
3. Lipinski"s rule of five descriptors plus the number of rotatable bonds.
Stepwise regression analysis was performed on the training sets using MINITAB Statistical Software (version 15.1.0.0) to select descriptors which had significant linear relationships with %HIA. %HIA was set as the dependant variable and the calculated molecular descriptors of the compounds set as independent variables. In order to minimise the risk of chance correlations, the maximum number of descriptors allowed in the models was restricted to eight. The descriptors selected by stepwise regression analysis were used in the models developed by regression and discriminant analysis. There were a significant number of compounds that had missing values for descriptors such as ACD_Density, therefore stepwise regression was carried out again excluding these descriptors and a second model was developed for the training sets.
Stepwise discriminant analysis was carried out using TSAR 3D. The selected descriptor set was solely used for the classification of the compounds into highly absorbed (%HIA ≥ 50%) or poorly absorbed groups (%HIA < 50%) and not for prediction of precise %HIA values using regression analysis.
Lipinski"s "rule of five" is a popular rapid screen to identify compounds that are poorly absorbed (Lipinski et al. 1997 ). The descriptors proposed by Lipinski are: molecular weight, number of hydrogen bonding donor and acceptor groups and logP. Number of rotatable bonds was also added, as it has been suggested to help predict oral bioavailability and hence oral absorption (Zakeri-Milani et al. 2006 ). This set of descriptors was used in regression and classification analysis.
Multiple Regression Analysis
Regression analyses on the descriptor sets selected using stepwise regression and the rule of five descriptors mentioned previously were carried using MINITAB statistical software.
%HIA was set as the dependant variable and the descriptor sets as independent variables.
For each regression analysis the following statistical criteria were obtained: N, the number of observations, r 2 , the squared correlation coefficient, S, the standard deviation, F, Fisher's criterion and p-value, the level of significance of the model. All the descriptors had a p-value of less than 0.05, indicating that they were all significant for the prediction of %HIA. From the predicted and observed %HIA data the RMSE (root mean squared error) was calculated for the training and validation sets separately.
Discriminant Analysis
Discriminant analysis is a statistical classification technique that examines the set of variables associated with a given subject and uses similarities and differences to assign the subject to a group or class. It is a classical statistical approach for classifying samples of unknown classes (validation set), based on samples from the training set with known classes. Discriminant analysis was carried out using MINITAB software to categorize drugs into classes of low or high absorption drugs. This analysis was done for the training set and then utilized to predict the absorption of drugs in the validation sets. Drugs with %HIA value greater than or equal to 50 were graded 1 (HIA+), while those with %HIA less than 50 were graded as 0 (HIA-). In this manner, predictive models were developed using the observed %HIA class as the response, and each set of the descriptors selected by stepwise regression analysis, stepwise discriminant descriptors and the rule of five descriptors as the predictors. The ability of each model to predict the %HIA classes of the compounds in the validation set was explored.
To assess and compare the models, the parameters of accuracy, specificity and sensitivity were calculated. Accuracy determines the overall % of correct classification of compounds using the model. Specificity highlights the correct classification of HIA-compounds, and sensitivity is equivalent to the correct classification of HIA+ compounds.
Results
The molecular descriptors used in the models are shown in Table 2 . A brief description of each descriptor is also included. 
Regression Models
Two regression models were developed for the training set TS1, which contained a similar number of drugs at each 10% range. These models were obtained using the descriptors selected by stepwise regression when all the descriptors were used in analysis (model 1) and when several descriptors with a high number of missing values (ACD density and logP) were excluded (model 2).
Model 1 There are 95 compounds in the dataset that were excluded by Hou et al (2007c) for a variety of reasons mentioned previously. The remaining outliers were removed from the dataset and regression analysis was performed again. When these compounds were excluded from the models above, the statistics were improved for both the training and validation sets. Table 3 shows the statistical parameters of the equations obtained for the training sets before and after the exclusion of the outliers. It must be noted that only some of the 95 outliers fell within the training sets and the remaining belonged to the validation set. In order for a better comparison of the models, RMSE values were calculated for the new validation set, VS3, containing 89 compounds for all 4 models. The results in Table 3 show that models 1 and 2 had the lowest RMSE values for this representative validation set.
Classification Models
Stepwise discriminant analysis using TSAR 3D selected seven descriptors for the It must be noted from Table 4 that for some of the models the overall accuracy is higher for the validation set compared to the training set. This is due to the biased distribution of %HIA of the compounds and lack of poorly/moderately absorbed compounds represented in dataset. t-training; v-validation; Accuracy shows the correct overall classification and is calculated by number of correct divided by overall number of compounds; Sensitivity is equivalent to the number of correctly classified HIA+ compounds and is calculated using SE=(TP/(TP+FN));
Specificity is equivalent to the number of correctly classified HIA-compounds and is calculated using SP=(TN/(TN+FP)); TP-true positive;
FN-False negative; TN-true negative; FP-false positive
In order to compare the models, the accuracy, sensitivity and sensitivity of discriminant analysis for the classification of the new validation set, VS3, (containing 89 compounds) for all 5 models was carried out and the results are in Tables 6 and 7 for TS1 and TS2. v-validation; Accuracy shows the correct overall classification and is calculated by number of correct divided by overall number of compounds; Sensitivity is equivalent to the number of correctly classified HIA+ compounds and is calculated using SE=(TP/(TP+FN));
Specificity is equivalent to the number of correctly classified HIA-compounds and is calculated using SP=(TN/(TN+FP)); TP-true positive; FN-False negative; TN-true negative; FP-false positive
Discussion
The aim of this study was to create models that could predict %HIA values or classify compounds into highly and poorly absorbed (HIA+ and HIA-) classes with emphasis on using a balanced training set data distribution to see if there was an improvement in prediction and classification ability for poorly absorbed compounds. Data splitting techniques such as Kennard-Stone algorithm (1969), which is used for the training set selection based on the molecular descriptor values, would not be useful in this case since the highly absorbed compounds cover a much larger descriptor space (Tropsha 2010) . For instance, it was observed in this data set that splitting the data based on the log P values, or based on the first or the second principal components from principle component analysis using all molecular descriptors will still select for the training set a majority of highly absorbed compounds (85%-86% highly absorbed). To overcome the well documented problem of highly biased training sets (towards the high absorbed compounds), a subset of the available data was selected with under-sampling of the majority group (highly absorbed compounds). The selected training set consisted of about ten compounds in each 10% %HIA ranges (94 in total). The models generated using this training set (TS1) were compared with the models generated for a randomly selected training set consisting 5/6 of the dataset entries (TS2).
Regression analysis and classification analysis results are discussed highlighting the best model for each type of analysis.
Regression Models
Regression models were generated using the randomly selected dataset (TS2) which contains many more highly absorbed compounds than compounds with intermediate or poor absorption and the balanced training set chosen by under-sampling the highly absorbed compounds (TS1). The most suitable equation based on the statistics for the training set was model 1 which used dataset TS1. Model 1 shows a slightly better fit to the training set than model 2 using the same training set.
Although in this study model 3 and 4 (developed using TS2) appeared to have poorer statistics for the training sets, the RMSE for the validation set is better than models 1 and 2.
However it must be noted that a direct comparison between models 1 and 2, with models 3 and 4 at this point is not coherent. This is because models 1 and 2 were derived from a small training set of 94 compounds (TS1) and evaluated using VS1, a large validation set (N=502), with a different %HIA distribution to the training set; whereas models 3 and 4 were derived using a much larger training set (TS2) and were evaluated using VS2, a smaller validation set that was representative of the training set in terms of %HIA distribution. Table 3 show that model 2 has the lowest RMSE value of 24.45. Models 3 and 4 have much larger RMSE values for the new validation set indicating that these models work well for estimation of %HIA of highly absorbed compounds (as shown by the results in Table 3 ), but the estimation accuracy is dropped when the validation set consists of roughly equal proportion of highly and poorly absorbed compounds (as shown in Table 3 ), which may be true in real life drug-candidates. This is expectable due to the highly biased nature of the training set used for the development of these models (TS2). Therefore, it can be concluded that for the real life scenarios, where a newly discovered drug candidate maybe expected to have approximately equal probability of being a highly or poorly absorbable drug, Model 2 may be a more accurate estimate of %HIA.
In this study there is not much difference between the RMSE and r 2 values of the models before and after the exclusion of the compounds that are believed to be absorbed actively or whose absorption are dissolution limited. This indicated that the effect of transporters does not have a significant effect on the goodness of fit of the regression models. This could be because for some compounds, although known to be absorbed via transporters, this process may not be the dominant one and the effect of the transporters is insignificant compared with passive diffusion of the compounds (Sugano et al. 2010) . So in practice, leaving these compounds in may be more realistic and help build generic models with a variety of absorption mechanisms, rather than removing these compounds and possibly reducing the applicability of the model (Suenderhauf et al. 2011) .
Model 2 contained the following descriptors: PSA, log D 7.4 , Ka3, SHBint2, aliphatic rings(5), SHBint2_Acnt, SpcPolarizability & SHBint3. All of the descriptors above can be used in combination to correlate with intestinal absorption; however the correlation decreases significantly when the descriptors are used independently, highlighting that absorption is a complex process and is reliant and influenced by a number of different descriptors, not just one (Clark 1999 (Clark , 2011 Stouch et al. 2003) .
PSA has been found to be the most popular descriptor used in prediction of intestinal absorption since its first use in relation to brain penetration (van de Waterbeemd and Kansy 1992) . It is a measure of the area of the Van der Waals surface that arises from oxygen and nitrogen atoms or hydrogen atoms bound to these atoms. PSA is related to hydrogen bonding capacity, which is one of the main influencers of passive drug absorption along with lipophilicity (Palm et al. 1996) . PSA is used more frequently and is deemed more suitable than normal hydrogen bonding potential descriptors as it accounts for the 3D effects of the molecule, such as shielding of the polar functional groups by other atoms. It has been shown that if a molecule has a PSA of ≥ 140Å, it is likely to have poor absorption (<10% FA) and if the molecule has a PSA ≤60Å, %FA values >90% can be achieved (Clark 1999; Hou et al. 2007c; Palm et al. 1997) . This is in agreement with our results as PSA has a negative impact on absorption. Hydrogen bonding ability has been further characterised in model 2 by three topological descriptors of SHBint2_Acnt, SHBint2 and SHBint3, all of which have negative coefficients in agreement with the literature.
Hydrophobicity is another physiologically important parameter in intestinal absorption and descriptors relating to it, such as logP and logD, have a positive contribution to the predictions for passively absorbed compounds (Zakeri-Milani et al. 2006 ). An increase in hydrophobicity would increase the permeation of the compound into and through the cell membrane in the intestine. However, it has been suggested that the relationship is non linear, so if the drug is too hydrophobic with a very high logD value for example it may not penetrate the membrane at all and can also cause solubility issues (Comer 2003; Kerns and Di 2008; Varma et al. 2010) . If the compound has a low logD value this could also prevent absorption but, if the compound is small, with a molecular weight less than 200 Da it may be absorbed via the paracellular route (Martinez and Amidon 2002; Stenberg et al. 2000) . In our equation logD 7.4 has been used, which is the apparent octanol/water partition coefficient at pH 7.4. This particular descriptor has been used in other studies, as well as other logD values at lower pH values (Hou et al. 2007b ). It has been indicated that although logP is easier to calculate from structure, logD has a better prediction ability as it takes into account the pH and ionisation (Egan et al. 2000; Hou et al. 2007a) . Studies have shown that a combination of PSA and logD have good prediction abilities for intestinal absorption, indicating that it is a combination of descriptors that influence predictions (Hou et al. 2009 ).
Suenderhauf et al (2011) and Hou et al (2006) have compiled summary tables containing information regarding the results for the models from previously published work. This enables us to compare our results to previous studies. However, it must be emphasized that it is very difficult to compare these models due to the lack of compound information regarding data distribution for the training and validation sets and lack of consistency in validation techniques (Stouch et al. 2003; The et al. 2011; Zhao et al. 2001 ). The only way this possibly could be done would be to mimic the datasets used and compare the models on previous works" datasets (Davis and Brunea 2003) .
Taking our best regression model, which was model 2 using dataset TS1 with exclusions an r 2 value of 0.785 was achieved with a RMSE for the training and validation set of 14.54 and 23.84. Other studies that used regression analysis such as Wessel et al (1998) , Zhao et al (2001) and Niwa et al (2003) are comparable to our model with regards to the training set.
However, the RMSE for our validation set is slightly higher apart from Niwa et al (2003) . Wessel et al (1998) achieved small RMSE values of 9.5% and 16% for the 76 and 10 compounds used in the training and validation sets. Zhao et al (2001) with an r 2 value of 0.83 achieved a RMSE of 14%. However, Zhao et al only had 131 and 38 compounds in the training and validation sets. The more recent study by Niwa et al (2003) showed that although a small RMSE value was achieved for the training set of 6.5% a much larger RMSE value was obtained for the validation set of 27.7. The numbers of compounds in the training and validation set were 67 and 9 compounds.
The studies mentioned so far have used small datasets and so might not be comparable with this work. Moreover, the comparison of the validation set compounds and distribution of compounds in them is not known. In fact, Klopman et al (2002) 
Classification Analysis
There are many advantages for the prediction of intestinal absorption. However, depending on the stage at which the prediction models are used, the need for precise values predicted by a regression method may be questionable, when classification methods can be used to define which drugs will be highly absorbed and likely to be administered orally and those which are not (Norinder et al. 1997; Suenderhauf et al. 2011) .
For the classification analysis, in order to classify which compounds would be grouped as HIA+ or HIA-, a cutoff of 50% of the %HIA value was defined (HIA+ denotes the high absorbance class, where %HIA is ≥ 50%, and HIA-denotes the low absorbance class, where %HIA is < 50%). The choice of 50% was arbitrary although it has also been used in previous studies (Niwa 2003) . There have been a number of different cutoffs used, from 10% (Palm et al. 1997) up to 70% (Xue et al. 2004) , with no standard defined. Table 4 , referring to models built from training set TS1, shows that for the classification of the validation set the best overall classification accuracy was 0.958 (481/502), the highest specificity value was 0.952 (441/460) and the best sensitivity was 0.959 (40/42), all using model 3. Model 3 also gives the best accuracy and specificity, and the second best sensitivity (after model 1) for VS1, the balanced validation set (see Table 6 ). However for this model, the overall accuracy and specificity are much lower for the training set compared with the validation set. In fact in most cases accuracy, specificity and sensitivity of many models are better for the validation set than for the training set. This can be due to the compound composition of the training and validation set with the training set containing, by random, more outlier compounds. Considering also the training set, the best model taking into account the overall accuracy, specificity and sensitivity values for the training and validation sets was The classification results obtained for TS2 (Table 5) indicate that the classification of poorly absorbed drugs (specificity values) are less accurate than the highly absorbed compounds (sensitivity). Moreover, the specificity values of the models developed using TS2 are much less accurate than models developed using TS1 (compare Tables 6 and 5 ). This is due to the unbalanced training set used (TS2) with a lower number of poorly absorbed compounds compared to highly absorbed compounds. On the other hand, sensitivity is higher in most models obtained for TS2, compared with models developed with TS1, with exceptions being the validation set sensitivity of model 3 and model 5.
For both TS1 and TS2 the effect of removal of the excluded compounds as highlighted by Hou et al (2007c) increased overall accuracy, specificity and sensitivity values in the majority of cases, but there was not a significant increase. So, as stated before, in practice leaving these compounds in will achieve a more applicable model that will have better generalization for new compounds.
Suenderhauf et al (2011) and Hou et al (2006) have compiled summary tables that detail the accuracy, specificity and sensitivity of previous classification work carried out by previous studies. Overall a similar pattern emerges that the overall accuracy and sensitivity values of previous studies are higher than the specificity values obtained. This could be due to the low ratio of HIA-compounds in the training sets. An exception to this pattern is the results obtained by Hou et al (2007c) , where specificity values in the validation set were higher than the sensitivity values. For our work, the overall accuracy and sensitivity are comparable or higher than previous studies apart from Hou et al (2007c) , who used the same dataset but excluded carrier mediated and poorly soluble compounds. They also included 26 compounds with positively charged nitrogen which are known to be poorly absorbed and predicted readily with a count of positively charged nitrogen atoms. This aids the statistics of their model by increasing the specificity. This is also the reason for the higher specificity compared with sensitivity in their model. We have not included these 26 compounds in our investigation. Also, it must be noted that in Hou"s investigation, the more complex non-linear methods of recursive partitioning and genetic function approximation (GFA) have been used (Hou et al, 2007c) . Again, as mentioned earlier it would be precarious to take results at face value without considering the real impact of this type of information such as number of compounds in each class in the training and validation sets.
There is a lot of business emphasis on reducing the number of false negatives in drug discovery due to the potential of missing the next potential drug and therefore potential loss of revenue, which is very important with the increased cost of drug discovery and development (Malo et al. 2006) . A reduction in the number of false negatives is favoured in most publications as in practice they are more difficult to assess and highlight, so a model with as low as possible false negative rate is preferred (Zhang et al. 2000 ). An example of this is Amlodipine, which was predicted to be poorly bioavailable by QSAR but in real life is highly bioavailable (Beresford et al. 2004) . However reducing the number of false positives could be considered equally as important or more important for cost effectiveness reasons. If a drug is misclassified as highly absorbed when in fact it is poorly absorbed (false positive) more time, effort and money is invested to investigate and reveal the compounds true class with further tests. Although there are few publications indicating that false positives need to be decreased rather than the business need of reducing false negatives, with the spiralling cost of drug discovery it maybe a future consideration for many companies to reduce false positives and therefore become more cost and time effective (Cummings 2006; Oprea 2000) .
Comparing the sensitivity and specificity values reported in Tables 7 and 8 for the consistent validation set of 89 compounds (VS3), it can be seen that the best specificity is achieved for models developed using TS1 (Table 6 ) with the highest value obtained using model 3. On the other hand the best sensitivity values were obtained using models developed using TS2 (Table 7) . This shows that TS1, the balanced dataset has a better classification ability compared with TS2 (unbalanced dataset) for predicting poorly absorbed compounds whereas TS2 has a better classification ability for highly absorbed compounds due to the biased nature of the dataset. In relation to the reduction of false positives and false negatives and depending on the priority, the balanced TS1 dataset would aid to reduce false positives by the increasing specificity and TS2 would increase sensitivity and therefore reduce false negatives. In conclusion if reducing the number of false positives is the priority then under-sampling of the majority class of the highly absorbed compounds would lead to more accurate and applicable in silico models for use in industry.
Conclusion
The importance of a good dataset is reiterated in numerous publications (Hou et al. 2009; Hou et al. 2007a; Tian et al. 2011; Zhu et al. 2011 ). There is a lack of publically available data to try and improve models for predicting intestinal absorption, however, even with more compounds it is the quality of the data which will then be questioned (Stouch et al. 2003) .
How the data is obtained and how it is validated are important issues to consider (Kortagere and Ekins 2010) . In this work the dataset of Hou et al (2007c) was used for the development and validation of the models. In order to improve the prediction accuracy for the poorly absorbed compounds, the training set was selected by under-sampling the highly absorbed compounds. Two types of linear methods were used for the development of the models:
linear discriminant analysis for the classification and multiple linear regression for the regression type analysis.
In terms of the linear regression models, results were conclusive that using the balanced dataset with similar proportions of various %HIA ranges leads to more robust models with lower prediction error for the validation set. This is despite the lower number of compounds in this training set (N=94), in comparison with the randomly selected training set of 496 compounds. It is interesting to note that the r 2 values of this study are comparable to some of the models obtained using a variety of more complex techniques such as SVM and GA feature selection, showing that simple regression can obtain just as good r 2 and fit for the prediction of %HIA (Reynolds et al. 2009; Yan et al. 2008 ).
The discriminant models for the classification of compounds into high and low absorption classes indicated that the use of the balanced training set significantly improves specificity of the models indicating the higher accuracy of the classification of poorly absorbed compounds. However the sensitivity of the models developed using the balanced training set was lower than the sensitivity of the models based on the randomly selected training set which is skewed towards the highly absorbed compounds. Therefore, it can be suggested that, for reducing the number of false positives, it is better to use the balanced training set, despite the smaller training set size due to the under-sampling of the majority class.
To conclude, this work highlights that by creating a balanced training set the more improved models which are also applicable to real life scenarios can be achieved for both regression and classification type analyses. It is envisaged that this conclusion may be extended to models based on more complex statistical techniques such as non-linear methods to improve the prediction accuracy further. Another significant point that needs to be considered in training set selection, in future research, is the impact of solubility and the dataset distribution of solubility values. Taking this into account may lead to even more applicable models given the increasing number of the poorly water-soluble and high molecular weight New Chemical Entities.
The need for in silico modeling for the prediction of absorption is still apparent. There are many mitigating factors that can affect the use of simple models, but they are still useful.
Even though different models were developed in this work, there were particular descriptors that were in more than one model. These descriptors help and confirm the understanding and the process of oral absorption. Descriptors such as logD, PSA and those involving H bonding are all known to have an impact, whether this is positively or negatively, on oral absorption.
There is still a wide scope for improving the prediction of models as there are many influencing factors that contribute towards absorption and therefore eventually oral bioavailability.
